{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:44:39Z","timestamp":1791377079688,"version":"4.3.2"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001655","name":"German Academic Exchange Service","doi-asserted-by":"publisher","award":["91795579"],"award-info":[{"award-number":["91795579"]}],"id":[{"id":"10.13039\/501100001655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001655","name":"German Academic Exchange Service","doi-asserted-by":"publisher","award":["91762223"],"award-info":[{"award-number":["91762223"]}],"id":[{"id":"10.13039\/501100001655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007653","name":"Universit\u00e4tsklinikum Jena","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"German Cancer Aid","doi-asserted-by":"publisher","award":["70113814"],"award-info":[{"award-number":["70113814"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jare.2025.05.019","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T11:09:58Z","timestamp":1747048198000},"page":"371-392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Induction of cellular senescence by androgen receptor agonist or antagonist is mediated via two novel common DYRK1A-DREAM and cyclin G2 signaling pathways in castration-resistant prostate cancer"],"prefix":"10.1016","volume":"80","author":[{"given":"Golnaz","family":"Atri Roozbahani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Heidari Horestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Kallenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aria","family":"Baniahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2025.05.019_b0005","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3390\/cancers15020461","article-title":"Metastatic prostate cancer\u2014a review of current treatment options and promising new approaches","volume":"15","author":"Posdzich","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.jare.2025.05.019_b0010","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/ijc.31818","article-title":"Interference with the androgen receptor protein stability in therapy\u2010resistant prostate cancer","volume":"144","author":"Lakshmana","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jare.2025.05.019_b0015","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1530\/JME-14-0203","article-title":"Androgens and androgen receptor signaling in prostate tumorigenesis","volume":"54","author":"Zhou","year":"2015","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.jare.2025.05.019_b0020","first-page":"3","article-title":"Androgen receptor structure, function and biology: from bench to bedside","volume":"37","author":"Davey","year":"2016","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.jare.2025.05.019_b0025","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1200\/EDBK_159248","article-title":"Emerging molecular biomarkers in advanced prostate cancer: translation to the clinic","volume":"36","author":"Beltran","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.jare.2025.05.019_b0030","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ctrv.2015.05.003","article-title":"The hallmarks of castration-resistant prostate cancers","volume":"41","author":"Katsogiannou","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jare.2025.05.019_b0035","article-title":"Androgen receptor signaling in prostate cancer development and progression","volume":"10","author":"Lonergan","year":"2011","journal-title":"J Carcinogenesis"},{"key":"10.1016\/j.jare.2025.05.019_b0040","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/2159-8290.CD-13-0142","article-title":"An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide)","volume":"3","author":"Korpal","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jare.2025.05.019_b0045","doi-asserted-by":"crossref","first-page":"9611","DOI":"10.1158\/0008-5472.CAN-05-0817","article-title":"Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient","volume":"65","author":"Yoshida","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2025.05.019_b0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12672-018-0353-6","article-title":"A Targeted Bivalent Androgen Receptor Binding Compound for Prostate Cancer Therapy","volume":"10","author":"Chowdhury","year":"2019","journal-title":"Hormones and Cancer"},{"key":"10.1016\/j.jare.2025.05.019_b0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jsbmb.2018.12.005","article-title":"Halogen-substituted anthranilic acid derivatives provide a novel chemical platform for androgen receptor antagonists","volume":"188","author":"Roell","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jare.2025.05.019_b0060","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.3390\/cancers13164025","article-title":"Antithetic hTERT regulation by androgens in prostate cancer cells: hTERT inhibition is mediated by the ING1 and ING2 tumor suppressors","volume":"13","author":"Bartsch","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jare.2025.05.019_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-13-214","article-title":"Supraphysiological androgen levels induce cellular senescence in human prostate cancer cells through the Src-Akt pathway","volume":"13","author":"Roediger","year":"2014","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jare.2025.05.019_b0070","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1200\/JCO.20.02759","article-title":"TRANSFORMER: a randomized phase II study comparing bipolar androgen therapy versus enzalutamide in asymptomatic men with castration-resistant metastatic prostate cancer","volume":"39","author":"Denmeade","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jare.2025.05.019_b0075","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/oncolo\/oyad055","article-title":"Bipolar androgen therapy followed by androgen receptor inhibition as sequential therapy for prostate cancer","volume":"28","author":"Denmeade","year":"2023","journal-title":"Oncologist"},{"key":"10.1016\/j.jare.2025.05.019_b0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejca.2022.12.001","article-title":"Updated analyses for RESTORE cohort C: A trial of bipolar androgen therapy for patients with newly castration-resistant prostate cancer","volume":"181","author":"Sena","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jare.2025.05.019_b0085","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.euros.2022.05.006","article-title":"Clinical efficacy of bipolar androgen therapy in men with metastatic castration-resistant prostate cancer and combined tumor-suppressor loss","volume":"41","author":"Markowski","year":"2022","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.jare.2025.05.019_b0090","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3390\/biomedicines11041105","article-title":"Strategies to re-sensitize castration-resistant prostate cancer to antiandrogen therapy","volume":"11","author":"Congregado Ruiz","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jare.2025.05.019_b0095","first-page":"2577","article-title":"Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer","volume":"54","author":"Thalmann","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2025.05.019_b0100","doi-asserted-by":"crossref","first-page":"59781","DOI":"10.18632\/oncotarget.10926","article-title":"Critical role of androgen receptor level in prostate cancer cell resistance to new generation antiandrogen enzalutamide","volume":"7","author":"Hoefer","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jare.2025.05.019_b0105","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.jare.2025.05.019_b0110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/jmcb\/mjw007","article-title":"The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells","volume":"8","author":"Esmaeili","year":"2016","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.jare.2025.05.019_b0115","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.drudis.2012.10.003","article-title":"Three-dimensional cell culture: the missing link in drug discovery","volume":"18","author":"Breslin","year":"2013","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jare.2025.05.019_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-024-03097-6","article-title":"The clock gene BHLHE40 and atypical CCNG2 control androgen-induced cellular senescence as a novel tumor suppressive pathway in prostate cancer","volume":"43","author":"Heidari Horestani","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jare.2025.05.019_b0125","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12672-020-00391-5","article-title":"Interleukin-23 represses the level of cell senescence induced by the androgen receptor antagonists enzalutamide and darolutamide in castration-resistant prostate cancer cells","volume":"11","author":"Gupta","year":"2020","journal-title":"Horm Cancer"},{"key":"10.1016\/j.jare.2025.05.019_b0130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4103\/0976-500X.119726","article-title":"How to calculate sample size in animal studies?","volume":"4","author":"Charan","year":"2013","journal-title":"J Pharmacol Pharmacother"},{"key":"10.1016\/j.jare.2025.05.019_b0135","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1158\/1078-0432.CCR-15-1147","article-title":"Androgen deprivation followed by acute androgen stimulation selectively sensitizes AR-positive prostate cancer cells to ionizing radiation androgen-induced radiosensitization in prostate cancer","volume":"22","author":"Hedayati","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jare.2025.05.019_b0140","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ymthe.2022.01.039","article-title":"Exploiting the tumor-suppressive activity of the androgen receptor by CDK4\/6 inhibition in castration-resistant prostate cancer","volume":"30","author":"Han","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.jare.2025.05.019_b0145","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.157164","article-title":"Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistrome","volume":"7","author":"Qiu","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.jare.2025.05.019_b0150","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1038\/s41388-022-02333-7","article-title":"The natural compound atraric acid suppresses androgen-regulated neo-angiogenesis of castration-resistant prostate cancer through angiopoietin 2","volume":"41","author":"Ehsani","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.jare.2025.05.019_b0155","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/ijc.32242","article-title":"Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models","volume":"145","author":"Sugawara","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jare.2025.05.019_b0160","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jare.2025.05.019_b0165","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2025.05.019_b0170","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"10.1016\/j.jare.2025.05.019_b0175","doi-asserted-by":"crossref","first-page":"W214","DOI":"10.1093\/nar\/gkq537","article-title":"The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function","volume":"38","author":"Warde-Farley","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jare.2025.05.019_b0180","doi-asserted-by":"crossref","unstructured":"Damian Szklarczyk AF, Stefan Wyder, Kristoffer Forslund, Davide Heller, Jaime Huerta-Cepas, Milan Simonovic, et al. (2015, Jan, 2015). STRING v10: protein-protein interaction networks, integrated over the tree of life. Available: http:\/\/string.embl.de\/.","DOI":"10.1093\/nar\/gku1003"},{"key":"10.1016\/j.jare.2025.05.019_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst Biol"},{"key":"10.1016\/j.jare.2025.05.019_b0190","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkae300","article-title":"SwissDock 2024: major enhancements for small-molecule docking with Attracting Cavities and AutoDock Vina","author":"Bugnon","year":"2024","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.jare.2025.05.019_b0195","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2. 0: New docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.jare.2025.05.019_b0200","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1158\/2159-8290.CD-20-1114","article-title":"RB\/E2F1 as a master regulator of cancer cell metabolism in advanced disease","volume":"11","author":"Mandigo","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jare.2025.05.019_b0205","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.3390\/ijms22052622","article-title":"TNMplot. com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues","volume":"22","author":"Bartha","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.05.019_b0210","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0006-291X(05)80067-1","article-title":"A mutation in the ligand binding domain of the androgen receptor of human INCaP cells affects steroid binding characteristics and response to anti-androgens","volume":"173","author":"Veldscholte","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jare.2025.05.019_b0215","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3390\/cells11060952","article-title":"Unravelling the role of kinases that underpin androgen signalling in prostate cancer","volume":"11","author":"Miller","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jare.2025.05.019_b0220","doi-asserted-by":"crossref","first-page":"10455","DOI":"10.1158\/0008-5472.CAN-07-2057","article-title":"Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity","volume":"67","author":"Zoubeidi","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2025.05.019_b0225","doi-asserted-by":"crossref","first-page":"12719","DOI":"10.1074\/jbc.RA118.003075","article-title":"Membrane-associated androgen receptor (AR) potentiates its transcriptional activities by activating heat shock protein 27 (HSP27)","volume":"293","author":"Li","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2025.05.019_b0230","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41391-020-0235-1","article-title":"Androgen receptor phosphorylation at serine 81 and serine 213 in castrate-resistant prostate cancer","volume":"23","author":"McAllister","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.jare.2025.05.019_b0235","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1056\/NEJMoa2001342","article-title":"Nonmetastatic, castration-resistant prostate cancer and survival with darolutamide","volume":"383","author":"Fizazi","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jare.2025.05.019_b0240","first-page":"1","article-title":"The androgen receptor\u2014lncRNASAT1-AKT-p15 axis mediates androgen-induced cellular senescence in prostate cancer cells","author":"Mirzakhani","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.jare.2025.05.019_b0245","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.3390\/nano10112236","article-title":"From 2D to 3D cancer cell models\u2014the enigmas of drug delivery research","volume":"10","author":"Van Zundert","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jare.2025.05.019_b0250","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1158\/1078-0432.CCR-21-0342","article-title":"Darolutamide potentiates the antitumor efficacy of a PSMA-targeted thorium-227 conjugate by a dual mode of action in prostate cancer models","volume":"27","author":"Hammer","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jare.2025.05.019_b0255","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1365-2826.2007.01592.x","article-title":"Androgen receptor expression in the levator ani muscle of male mice","volume":"19","author":"Johansen","year":"2007","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.jare.2025.05.019_b0260","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1038\/sj.onc.1209651","article-title":"Retinoblastoma family genes","volume":"25","author":"Du","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.jare.2025.05.019_b0265","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1038\/sj.onc.1206487","article-title":"Triggering of p73-dependent apoptosis in osteosarcoma is under the control of E2Fs\u2013pRb2\/p130 complexes","volume":"22","author":"La Sala","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jare.2025.05.019_b0270","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-22-2613","article-title":"Supraphysiological androgens promote the tumor suppressive activity of the androgen receptor through cMYC repression and recruitment of the DREAM complex","author":"Nyquist","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2025.05.019_b0275","article-title":"Comprehensive analysis of the expression and prognosis for the DREAM complex in human cancers","volume":"13","author":"Wang","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.jare.2025.05.019_b0280","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrc3556","article-title":"The DREAM complex: master coordinator of cell cycle-dependent gene expression","volume":"13","author":"Sadasivam","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jare.2025.05.019_b0285","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1210\/me.2012-1016","article-title":"Direct cooperation between androgen receptor and E2F1 reveals a common regulation mechanism for androgen-responsive genes in prostate cells","volume":"26","author":"Altintas","year":"2012","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jare.2025.05.019_b0290","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/1878-0261.12693","article-title":"Darolutamide antagonizes androgen signaling by blocking enhancer and super\u2010enhancer activation","volume":"14","author":"Baumgart","year":"2020","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jare.2025.05.019_b0295","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.yhbeh.2007.09.012","article-title":"An alternate pathway for androgen regulation of brain function: Activation of estrogen receptor beta by the metabolite of dihydrotestosterone, 5\u03b1-androstane-3\u03b2, 17\u03b2-diol","volume":"53","author":"Handa","year":"2008","journal-title":"Horm Behav"},{"key":"10.1016\/j.jare.2025.05.019_b0300","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1101\/gad.2034211","article-title":"DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly","volume":"25","author":"Litovchick","year":"2011","journal-title":"Genes Dev"},{"key":"10.1016\/j.jare.2025.05.019_b0305","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1158\/1541-7786.MCR-16-0323-T","article-title":"A systematic analysis of negative growth control implicates the DREAM complex in cancer cell dormancy","volume":"15","author":"MacDonald","year":"2017","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.jare.2025.05.019_b0310","article-title":"Tumor suppressor DYRK1A effects on proliferation and chemoresistance of AML cells by downregulating c-Myc","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jare.2025.05.019_b0315","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1007\/s13277-013-1389-4","article-title":"Effect of cyclin G2 on proliferative ability of prostate cancer PC-3 cell","volume":"35","author":"Cui","year":"2014","journal-title":"Tumor Biol"},{"key":"10.1016\/j.jare.2025.05.019_b0320","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1158\/1535-7163.MCT-15-0892","article-title":"The effect of F877L and T878A mutations on androgen receptor response to enzalutamide","volume":"15","author":"Prekovic","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jare.2025.05.019_b0325","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2174\/1871520611313050014","article-title":"Computational and functional analysis of the androgen receptor antagonist atraric acid and its derivatives","volume":"13","author":"Papaioannou","year":"2013","journal-title":"Anti-Cancer Agents Med Chem (Formerly Current Medicinal Chemistry-Anti-Cancer Agents)"},{"key":"10.1016\/j.jare.2025.05.019_b0330","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41419-022-05084-1","article-title":"Second generation androgen receptor antagonists and challenges in prostate cancer treatment","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jare.2025.05.019_b0335","first-page":"146","article-title":"A new class of AR antagonists?","volume":"16","author":"Fenner","year":"2019","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.jare.2025.05.019_b0340","doi-asserted-by":"crossref","unstructured":"Cheung S, Jain P, So J, Shahidi S, Chung S, Koritzinsky M. p38 MAPK Inhibition Mitigates Hypoxia-Induced AR Signaling in Castration-Resistant Prostate Cancer. Cancers 2021, 13, 831. ed: s Note: MDPI stays neutral with regard to jurisdictional claims in published; 2021.","DOI":"10.3390\/cancers13040831"},{"key":"10.1016\/j.jare.2025.05.019_b0345","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010563","article-title":"Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study","volume":"7","author":"Schweizer","year":"2015","journal-title":"Sci Translat Med"},{"key":"10.1016\/j.jare.2025.05.019_b0350","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12672-020-00391-5","article-title":"Interleukin-23 represses the level of cell senescence induced by the androgen receptor antagonists enzalutamide and darolutamide in castration-resistant prostate cancer cells","volume":"11","author":"Gupta","year":"2020","journal-title":"Hormones Cancer"},{"key":"10.1016\/j.jare.2025.05.019_b0355","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.18632\/aging.204743","article-title":"Key elements of cellular senescence involve transcriptional repression of mitotic and DNA repair genes through the p53-p16\/RB-E2F-DREAM complex","volume":"15","author":"Kandhaya-Pillai","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jare.2025.05.019_b0360","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/ijms26010322","article-title":"Emerging role of the DREAM complex in cancer and therapeutic opportunities","volume":"26","author":"Hwang","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.05.019_b0365","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1002\/mog2.61","article-title":"Cellular senescence: A potential mode of circular RNAs regulating prostate cancer","volume":"2","author":"Li","year":"2023","journal-title":"MedComm\u2013Oncology"},{"key":"10.1016\/j.jare.2025.05.019_b0370","article-title":"A new perspective on prostate cancer treatment: the interplay between cellular senescence and treatment resistance","volume":"15","author":"Xu","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jare.2025.05.019_b0375","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nature05327","article-title":"Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication","volume":"444","author":"Di Micco","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jare.2025.05.019_b0380","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.3390\/ijms20081810","article-title":"miR-590-3p targets cyclin G2 and FOXO3 to promote ovarian cancer cell proliferation, invasion, and spheroid formation","volume":"20","author":"Salem","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.05.019_b0385","article-title":"MiR-1290 targets CCNG2 to promote the metastasis of oral squamous cell carcinoma","volume":"23","author":"Qin","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jare.2025.05.019_b0395","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcac009","article-title":"TargetGeneReg 2.0: a comprehensive web-atlas for p53, p63, and cell cycle-dependent gene regulation","volume":"4","author":"Fischer","year":"2022","journal-title":"NAR Cancer"},{"key":"10.1016\/j.jare.2025.05.019_b0400","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1080\/15384101.2016.1243189","article-title":"Cyclin G2 promotes cell cycle arrest in breast cancer cells responding to fulvestrant and metformin and correlates with patient survival","volume":"15","author":"Zimmermann","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jare.2025.05.019_b0405","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1172\/JCI122819","article-title":"Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer","volume":"129","author":"Sharp","year":"2019","journal-title":"J Clin Invest"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225003121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225003121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T01:17:18Z","timestamp":1769822238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123225003121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":80,"alternative-id":["S2090123225003121"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2025.05.019","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of cellular senescence by androgen receptor agonist or antagonist is mediated via two novel common DYRK1A-DREAM and cyclin G2 signaling pathways in castration-resistant prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2025.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}